Paul Hauptman
Cardiovascular Disease · St Louis, MONPI 1619987930
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $118,138 of the $124,167 with a category attached, or 95.1%. 8 manufacturers reported payments, led by Abbott at 50.1% of the total. Reporting peaked in 2019 at $73,691 and has fallen 87.4% since, to $9,300 in 2024. Among cardiovascular disease clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $811.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$62K
- Livanova USA, Inc.$33K
- Novo Nordisk$9K
- Vifor Pharma, Inc.$7K
- Pfizer$6K
- AstraZeneca$6K
- plus $30 from 2 others
Across 15 payments — averaging $1147.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$12K
- Boehringer Ingelheim Pharma GmbH & Co.kg$6K
What the payments were for
- Consulting fees$118,13895%
- Travel & lodging$3,3853%
- Food & beverage$2,6442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 79 | $62,181 |
| Livanova USA, Inc. | 43 | $33,368 |
| Novo Nordisk | 1 | $9,300 |
| Vifor Pharma, Inc. | 10 | $6,690 |
| Pfizer | 11 | $6,400 |
| AstraZeneca | 7 | $6,199 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Biosense Webster, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CardioMEMS HF System$45,838
- VNS - Vitaria$17,480
- VNS Therapy$15,888
- CentriMag$14,060
- Veltassa$6,576
- FARXIGA$6,064
How this compares
$124,167 in reported general payments places this provider in the 95th percentile of 391 cardiovascular disease providers in Missouri.
Other cardiovascular disease in St Louis
- Bernard ChaitmanSt Louis$121K
- Mikhail KosiborodKansas City$1.1M
- Georges ChahoudSaint Louis$937K
- William BowenSaint Louis$726K
- Daniel KellySaint Louis$582K
- John SpertusKansas City$360K
- James FairlambColumbia$342K
- James EllisonChesterfield$267K
- Osler Jay GuzonSaint Louis$211K
- Matthew FraleyFlorissant$183K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.